313 A pathogenic role for Th22/IL-22 in atopic dermatitis is established by a placebo-controlled trial with an anti IL-22/ILV-094 mAb
暂无分享,去创建一个
M. Lebwohl | A. Neumann | M. Suárez-Fariñas | J. Krueger | S. Garcet | J. Fuentes-Duculan | P. Brunner | E. Guttman‐Yassky | S. Khattri | K. Malik